Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

1. Stellbrink, H.-J.
2. Reynes, J.
3. Lazzarin, A.
4. Voronin, E.
5. Pulido, F.
6. Felizarta, F.
7. Almond, S.
8. Clair, M.S.
9. Flack, N.
10. Min, S.